In Vitro and In Vivo Efficacy Studies of Lavender angustifolia Essential Oil and Its Active Constituents on the Proliferation of Human Prostate Cancer Y Zhao, R Chen, Y Wang, C Qing, W Wang, Y Yang Integrative cancer therapies 16 (2), 215-226, 2017 | 101 | 2017 |
α-Pinene inhibits human prostate cancer growth in a mouse xenograft model Y Zhao, R Chen, Y Wang, Y Yang Chemotherapy 63 (1), 1-7, 2018 | 70 | 2018 |
Prodrug strategy for PSMA-targeted delivery of TGX-221 to prostate cancer cells Y Zhao, S Duan, X Zeng, C Liu, NM Davies, B Li, ML Forrest Molecular pharmaceutics 9 (6), 1705-1716, 2012 | 67 | 2012 |
Vorinostat with sustained exposure and high solubility in poly (ethylene glycol)‐b‐poly (dl‐lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics … EA Mohamed, Y Zhao, MM Meshali, CM Remsberg, TM Borg, AMM Foda, ... Journal of pharmaceutical sciences 101 (10), 3787-3798, 2012 | 51 | 2012 |
CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy Y Zhao, T Zhang, S Duan, NM Davies, ML Forrest Nanomedicine: Nanotechnology, Biology and Medicine 10 (6), 1221-1230, 2014 | 39 | 2014 |
Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice R Chen, Y Zhao, Y Huang, Q Yang, X Zeng, W Jiang, J Liu, JB Thrasher, ... The Prostate 75 (6), 593-602, 2015 | 27 | 2015 |
Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice W Jiang, B Li, M Laird Forrest, J Brantley Thrasher, J Liu, R Chen, Y Zhao, ... | 27* | 2015 |
Linalool inhibits 22Rv1 prostate cancer cell proliferation and induces apoptosis Y Zhao, X Cheng, G Wang, Y Liao, C Qing Oncology Letters 20 (6), 1-1, 2020 | 26 | 2020 |
Combination immunotherapy approaches for pancreatic cancer treatment X Cheng, G Zhao, Y Zhao Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 22 | 2018 |
Smart Polymeric Nanoparticles in Cancer Immunotherapy Z Yu, X Shen, H Yu, H Tu, C Chittasupho, Y Zhao Pharmaceutics 15 (3), 775, 2023 | 20 | 2023 |
Sequential Drug Delivery in Targeted Cancer Therapy H Yu, N Ning, X Meng, C Chittasupho, L Jiang, Y Zhao Pharmaceutics 14 (3), 573, 2022 | 17 | 2022 |
Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat CM Remsberg, Y Zhao, JK Takemoto, RM Bertram, NM Davies, ... Pharmaceutics 5 (1), 81-93, 2012 | 17 | 2012 |
Synergism of Dam, MutH, and MutS in methylation-directed mismatch repair in Escherichia coli C Hu, Y Zhao, H Sun, Y Yang Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 795, 31-33, 2017 | 15 | 2017 |
Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis Z Yan, K Yang, X Tang, Y Bi, Y Ding, M Deng, D Xia, Y Zhao, T Chen Journal of Immunology Research 2022, 2022 | 13 | 2022 |
Correction to: Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. S Alrushaid, Y Zhao, CL Sayre, ZH Maayah, ML Forrest, SN Senadheera, ... Drug delivery and translational research 8 (5), 1592, 2018 | 13* | 2018 |
Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative S Alrushaid, Y Zhao, CL Sayre, ZH Maayah, M Laird Forrest, ... Drug delivery and translational research 7 (4), 582-597, 2017 | 13 | 2017 |
Structural Characterization of Polysaccharides Isolated from Panax notoginseng Medicinal Residue and Its Protective Effect on Myelosuppression Induced by … Y Liu, S Li, M Pu, H Qin, H Wang, Y Zhao, T Chen Chemistry & Biodiversity 19 (1), e202100681, 2022 | 12 | 2022 |
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy L Dong, X Tian, Y Zhao, H Tu, A Wong, Y Yang International Journal of Molecular Sciences 23 (23), 14775, 2022 | 9 | 2022 |
A collective statement in support of saving pangolins SW Choo, JL Chong, P Gaubert, AC Hughes, S O'Brien, AL Chaber, ... Science of the Total Environment, 2022 | 7 | 2022 |
The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells L Jiang, H Yu, C Wang, F He, Z Shi, H Tu, N Ning, S Duan, Y Zhao Pharmaceuticals 15 (10), 1271, 2022 | 6 | 2022 |